These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 20821718

  • 1. Environmental risk assessment of ivermectin: A case study.
    Liebig M, Fernandez AA, Blübaum-Gronau E, Boxall A, Brinke M, Carbonell G, Egeler P, Fenner K, Fernandez C, Fink G, Garric J, Halling-Sørensen B, Knacker T, Krogh KA, Küster A, Löffler D, Cots MA, Pope L, Prasse C, Römbke J, Rönnefahrt I, Schneider MK, Schweitzer N, Tarazona JV, Ternes TA, Traunspurger W, Wehrhan A, Duis K.
    Integr Environ Assess Manag; 2010 Jul; 6 Suppl():567-87. PubMed ID: 20821718
    [Abstract] [Full Text] [Related]

  • 2. A ranking of European veterinary medicines based on environmental risks.
    Kools SA, Boxall A, Moltmann JF, Bryning G, Koschorreck J, Knacker T.
    Integr Environ Assess Manag; 2008 Oct; 4(4):399-408. PubMed ID: 18563959
    [Abstract] [Full Text] [Related]

  • 3. Effects of the veterinary pharmaceutical ivermectin on soil invertebrates in laboratory tests.
    Römbke J, Krogh KA, Moser T, Scheffczyk A, Liebig M.
    Arch Environ Contam Toxicol; 2010 Feb; 58(2):332-40. PubMed ID: 19882295
    [Abstract] [Full Text] [Related]

  • 4. Effects of ivermectin-spiked cattle dung on a water-sediment system with the aquatic invertebrates Daphnia magna and Chironomus riparius.
    Schweitzer N, Fink G, Ternes TA, Duis K.
    Aquat Toxicol; 2010 May 10; 97(4):304-13. PubMed ID: 20060604
    [Abstract] [Full Text] [Related]

  • 5. Assessment of the environmental fate and effects of ivermectin in aquatic mesocosms.
    Sanderson H, Laird B, Pope L, Brain R, Wilson C, Johnson D, Bryning G, Peregrine AS, Boxall A, Solomon K.
    Aquat Toxicol; 2007 Dec 30; 85(4):229-40. PubMed ID: 17963854
    [Abstract] [Full Text] [Related]

  • 6. Semifield assessment of the runoff potential and environmental risk of the parasiticide drug ivermectin under Mediterranean conditions.
    Fernández C, Porcel MA, Alonso A, San Andrés M, Tarazona JV.
    Environ Sci Pollut Res Int; 2011 Aug 30; 18(7):1194-201. PubMed ID: 21373858
    [Abstract] [Full Text] [Related]

  • 7. Assessing effects of the pharmaceutical ivermectin on meiobenthic communities using freshwater microcosms.
    Brinke M, Höss S, Fink G, Ternes TA, Heininger P, Traunspurger W.
    Aquat Toxicol; 2010 Aug 15; 99(2):126-37. PubMed ID: 20451263
    [Abstract] [Full Text] [Related]

  • 8. Environmental risk assessment of veterinary pharmaceuticals: development of a standard laboratory test with the dung beetle Aphodius constans.
    Römbke J, Hempel H, Scheffczyk A, Schallnass HJ, Alvinerie M, Lumaret JP.
    Chemosphere; 2007 Nov 15; 70(1):57-64. PubMed ID: 17825355
    [Abstract] [Full Text] [Related]

  • 9. Environmental risk assessment of human pharmaceuticals in the European Union: A case study with the β-blocker atenolol.
    Küster A, Alder AC, Escher BI, Duis K, Fenner K, Garric J, Hutchinson TH, Lapen DR, Péry A, Römbke J, Snape J, Ternes T, Topp E, Wehrhan A, Knacker T.
    Integr Environ Assess Manag; 2010 Jul 15; 6 Suppl():514-23. PubMed ID: 19886730
    [Abstract] [Full Text] [Related]

  • 10. New test strategy for dung beetles during the authorization process of parasiticides.
    Adler N, Bachmann J, Römbke J.
    Integr Environ Assess Manag; 2013 Jul 15; 9(3):524-30. PubMed ID: 23325499
    [Abstract] [Full Text] [Related]

  • 11. Effects of the parasiticide ivermectin on the cladoceran Daphnia magna and the green alga Pseudokirchneriella subcapitata.
    Garric J, Vollat B, Duis K, Péry A, Junker T, Ramil M, Fink G, Ternes TA.
    Chemosphere; 2007 Oct 15; 69(6):903-10. PubMed ID: 17624408
    [Abstract] [Full Text] [Related]

  • 12. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.
    Besse JP, Garric J.
    Toxicol Lett; 2008 Jan 30; 176(2):104-23. PubMed ID: 18077113
    [Abstract] [Full Text] [Related]

  • 13. Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures.
    Klecka G, Persoon C, Currie R.
    Rev Environ Contam Toxicol; 2010 Jan 30; 207():1-93. PubMed ID: 20652664
    [Abstract] [Full Text] [Related]

  • 14. Are the parasiticidal avermectins resistant to dissipation in the environment? The case of eprinomectin.
    Litskas VD, Karamanlis XN, Batzias GC, Tsiouris SE.
    Environ Int; 2013 Oct 30; 60():48-55. PubMed ID: 24013019
    [Abstract] [Full Text] [Related]

  • 15. Analysis and dissipation of the antiparasitic agent ivermectin in cattle dung under different field conditions.
    Wohde M, Blanckenhorn WU, Floate KD, Lahr J, Lumaret JP, Römbke J, Scheffczyk A, Tixier T, Düring RA.
    Environ Toxicol Chem; 2016 Aug 30; 35(8):1924-33. PubMed ID: 27100922
    [Abstract] [Full Text] [Related]

  • 16. Tiered environmental risk assessment of methyltins from heat stabilizers in rigid PVC in Sweden.
    van Dokkum HP, Huwer SL.
    Regul Toxicol Pharmacol; 2005 Feb 30; 41(1):73-81. PubMed ID: 15649829
    [Abstract] [Full Text] [Related]

  • 17. Ecotoxicity of the veterinary pharmaceutical ivermectin tested in a soil multi-species (SMS) system.
    Jensen J, Scott-Fordsmand JJ.
    Environ Pollut; 2012 Dec 30; 171():133-9. PubMed ID: 22906622
    [Abstract] [Full Text] [Related]

  • 18. Aquatic toxicity of ivermectin in cattle dung assessed using microcosms.
    Mesa LM, Lindt I, Negro L, Gutierrez MF, Mayora G, Montalto L, Ballent M, Lifschitz A.
    Ecotoxicol Environ Saf; 2017 Oct 30; 144():422-429. PubMed ID: 28654874
    [Abstract] [Full Text] [Related]

  • 19. Effects of ivermectin application on the diversity and function of dung and soil fauna: Regulatory and scientific background information.
    Adler N, Bachmann J, Blanckenhorn WU, Floate KD, Jensen J, Römbke J.
    Environ Toxicol Chem; 2016 Aug 30; 35(8):1914-23. PubMed ID: 26573955
    [Abstract] [Full Text] [Related]

  • 20. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001.
    Straub JO.
    Toxicol Lett; 2002 May 10; 131(1-2):137-43. PubMed ID: 11988366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.